135 related articles for article (PubMed ID: 37987175)
1. Comparison of the long-term and short-term protection in mouse model of Leishmania major infection following vaccination with Live Iranian Lizard Leishmania mixed with chitin microparticles.
Noroozbeygi M; Keshavarzian N; Haji Molla Hoseini M; Haghdoust S; Yeganeh F
Parasite Immunol; 2024 Jan; 46(1):e13018. PubMed ID: 37987175
[TBL] [Abstract][Full Text] [Related]
2. A candidate vaccine composed of live nonpathogenic Iranian Lizard Leishmania mixed with Chitin microparticles protects mice against Leishmania major infection.
Haghdoust S; Noroozbeygi M; Hajimollahoseini M; Masooleh MM; Yeganeh F
Acta Trop; 2022 Mar; 227():106298. PubMed ID: 34971566
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Leishmanization Using
Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
Front Immunol; 2020; 11():1725. PubMed ID: 33193290
[No Abstract] [Full Text] [Related]
4. Co-administration of chitin micro-particle and Leishmania antigen proposed a new immune adjuvant against experimental leishmaniasis.
Azizi M; Yousefi R; Yeganeh F; Mami S; Haji Molla Hoseini M
Parasite Immunol; 2019 Dec; 41(12):e12676. PubMed ID: 31593609
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.
Salari S; Sharifi I; Keyhani AR; Ghasemi Nejad Almani P
Parasit Vectors; 2020 Aug; 13(1):415. PubMed ID: 32787908
[TBL] [Abstract][Full Text] [Related]
6. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of chitin microparticles on Leishmania major-infected BALB/c mice.
Ghotloo S; Hoseini MH; Alimohammadian MH; Khaze V; Memarnejadian A; Rostami A
Parasitol Int; 2015 Apr; 64(2):219-21. PubMed ID: 25543078
[TBL] [Abstract][Full Text] [Related]
8. Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
Maspi N; Ghaffarifar F; Sharifi Z; Dalimi A
Parasite Immunol; 2016 Apr; 38(4):228-35. PubMed ID: 26868280
[TBL] [Abstract][Full Text] [Related]
9. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis.
Okwor I; Liu D; Uzonna J
Vaccine; 2009 Apr; 27(19):2554-62. PubMed ID: 19428861
[TBL] [Abstract][Full Text] [Related]
10. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
[TBL] [Abstract][Full Text] [Related]
11. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
[TBL] [Abstract][Full Text] [Related]
12. Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.
Mazumder S; Maji M; Das A; Ali N
PLoS One; 2011 Feb; 6(2):e14644. PubMed ID: 21311597
[TBL] [Abstract][Full Text] [Related]
13. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
16. EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.
Seif S; Kazemi F; Gholami E; Seyed N; Taslimi Y; Habibzadeh S; Azarian B; Jamshidi S; Hashemi M; Rafati S; Taheri T
Appl Microbiol Biotechnol; 2016 May; 100(9):3923-34. PubMed ID: 26685673
[TBL] [Abstract][Full Text] [Related]
17. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
[TBL] [Abstract][Full Text] [Related]
19. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection.
Gicheru MM; Olobo JO; Anjili CO; Orago AS; Modabber F; Scott P
Infect Immun; 2001 Jan; 69(1):245-51. PubMed ID: 11119512
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and potential protection of DNA vaccine of Leishmania martiniquensis against Leishmania infection in mice.
Aunguldee T; Gerdprasert O; Tangteerawatana P; Jariyapongskul A; Leelayoova S; Wongsatayanon BT
J Infect Dev Ctries; 2021 Sep; 15(9):1328-1338. PubMed ID: 34669604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
